Surprised at the price action considering the fact that the primary endpoint is unlikely to be met. Add the history of prior troubles with the drug. Watching this space with interest nonetheless.
- Forums
- ASX - By Stock
- PTX
- Ann: Third complete response in PTX-200 AML Trial
Ann: Third complete response in PTX-200 AML Trial, page-206
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.23M |
Open | High | Low | Value | Volume |
4.5¢ | 4.5¢ | 4.3¢ | $36.04K | 810.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 4.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.5¢ | 974 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.044 |
1 | 330000 | 0.043 |
3 | 246000 | 0.041 |
7 | 925642 | 0.040 |
3 | 95000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.045 | 974 | 1 |
0.047 | 63339 | 2 |
0.049 | 114091 | 2 |
0.050 | 236935 | 5 |
0.051 | 19607 | 1 |
Last trade - 13.57pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
PTX (ASX) Chart |